[1] TILLETT W S,FRANCIS T.Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus[J].J Exp Med,1930,52(4):561-571.
[2] 纪国业,王斌,杜江,等.不同时间血液灌流对脓毒症兔血IL-6及TNF-α水平的影响[J].现代医学,2011,39(2):129-133.
[3] THOMPSON D,PEPYS M B,WOOD S P.The physiological structure of human C-reactive protein and its complex with phosphocholine[J].Structure,1999,7(2):169-177.
[4] PEPYS M B,HIRSCHFIELD G M.C-reactive protein:a critical update[J].J Clin Invest,2003,111(12):1805-1812.
[5] RIDKER P M,CUSHMAN M,STAMPFER M J,et al.Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men[J].N Engl J Med,1997,336(14):973-979.
[6] DEHGHAN A,KARDYS I,de MAAT M P,et al.Genetic variation,C-reactive protein levels,and incidence of diabetes[J].Diabetes,2007,56(3):872-878.
[7] PRADHAN A D,MANSON J E,RIFAI N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus[J].JAMA,2001,286(3):327-334.
[8] 洪永青,朱蓉,孟自力.血清炎性因子CRP、IL-6和TNF-α在慢性阻塞性肺疾病继发肺动脉高压中的研究[J].中国现代医学杂志,2013(33):27-31.
[9] CHANG M K,BINDER C J,TORZEWSKI M,et al.C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand:phosphorylcholine of oxidized phospholipids[J].Proc Natl Acad Sci USA,2002,99(20):13043-13048.
[10] STRANG F,SCHUNKERT H.C-reactive protein and coronary heart disease:all said——is not it?[J].Mediators Inflamm,2014,2014:1-7.
[11] VOLANAKIS J E,KAPLAN M H.Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide[J].Proc Soc Exp Biol Med,1971,136(2):612-614.
[12] de BEER F C,BALTZ M L,MUNN E A,et al.Isolation and characterization of C-reactive protein and serum amyloid P component in the rat[J].Immunology,1982,45(1):55-70.
[13] TEUPSER D,WEBER O,RAO T N,et al.No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice[J].J Biol Chem,2011,286(8):6272-6279.
[14] TRION A,de MAAT M P,JUKEMA J W,et al.No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice[J].Arterioscler Thromb Vasc Biol,2005,25(8):1635-1640.
[15] HIRSCHFIELD G M,GALLIMORE J R,KAHAN M C,et al.Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice[J].Proc Natl Acad Sci USA,2005,102(23):8309-8314.
[16] SIMONS J P,LOEFFLER J M,AL-SHAWI R,et al.C-reactive protein is essential for innate resistance to pneumococcal infection[J].Immunology,2014,142(3):414-420. |